SAKK-EORTC-10994, NCT00017095: Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer |
|
|
| Completed | 3 | 1856 | Europe | filgrastim, cyclophosphamide, docetaxel, epirubicin hydrochloride, fluorouracil, microarray analysis, immunohistochemistry staining method, laboratory biomarker analysis, biopsy, conventional surgery, neoadjuvant therapy, radiation therapy | European Organisation for Research and Treatment of Cancer - EORTC, Swedish Breast Cancer Group, Swiss Group for Clinical Cancer Research, Anglo Celtic Cooperative Oncology Group | Breast Cancer | 11/06 | | | |
